✦ LIBER ✦

Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer

✍ Scribed by K.K. Shih; D.S. Chi; R.R. Barakat; M.M. Leitao Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tertiary cytoreduction in patients with

✍ K.K. Shih; D.S. Chi; R.R. Barakat; M.M. Leitao Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Laparoscopic Cytoreduction for Advanced

✍ Nezhat, F.R.; Cho, J.E.; Liu, C.; Gretz, H.; Chuang, L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Phase II evaluation of topotecan and nav

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall K. Gibb; Lynne Lipp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Phase II study of bevacizumab and pemetr

✍ Hagemann, Andrea R.; Novetsky, Akiva P.; Zighelboim, Israel; Gao, Feng; Massad, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Clinical Outcome of Tertiary Surgical Cy

✍ Christina Fotopoulou; Rolf Richter; Ioana Elena Braicu; Sven-Christian Schmidt; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 291 KB

Bevacizumab Combination Therapy: A Revie

✍ Dhillon, Sohita 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 503 KB